Edema reduction trial for early brain bleed treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a combination of blood pressure medicines can reduce swelling after a brain bleed (intracerebral hemorrhage). It aims to help patients who are treated early—within 3 days of symptom onset—and are not having surgery to remove the clot.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had a brain bleed (not from an injury) that affects one of the upper parts of your brain
- Your symptoms started within the last 3 days (72 hours)
- A CT scan shows the bleed is at least the size of a small grape (3 mL)
- You are not scheduled for surgery to remove the blood clot
- You or your family member can give permission for you to join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation and changes in the blood-brain barrier occur after a spontaneous brain bleed. Researchers use special brain imaging and scans to understand these processes, which may help improve treatment in the future.
This trial tests a non-invasive ultrasound device to help clear blood clots from the brain after a spontaneous bleed. It may be an option for people with small to medium-sized bleeds who do not need surgery.
This study collects blood samples from people with and without bleeding risk to test a clot-dissolving drug (tPA) outside the body. It aims to improve minimally invasive surgery for brain hemorrhages.
This trial tests a combination of medicines given early after a large ischemic stroke to reduce brain swelling. It may help people who have had a stroke in the middle cerebral artery within the last 3 days and have a large area of brain damage.
This trial tests whether giving tranexamic acid (a medicine that helps clots stay stable) along with intensive blood pressure lowering can reduce bleeding in the brain and improve recovery. It is for people who arrive at the hospital very quickly after a hemorrhagic stroke.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.